ag019
Cell therapyexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 27, 2018 (NCT03751007)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03751007 | Phase 1/Phase 2 (Phase 2) | Oct 27, 2018 | Intrexon, Katholieke Universiteit Leuven, Precigen Actobio, TFS Trial Form Support, Yale University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Intrexon | For profit | 1 | 1 | 1 | 2018 |
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Precigen Actobio | For profit | 1 | 0 | 1 | 2018 |
| TFS Trial Form Support | For profit | 1 | 0 | 1 | 2018 |
| Yale University | Academic/Hospital | 1 | 0 | 1 | 2018 |
5 organizations
Page 1 / 1